Muscle Function, Muscle Disease, and Positron Emission Tomography-Computed Tomography: A Narrative Review

Furkejuvvon:
Bibliográfalaš dieđut
Publikašuvnnas:Cureus vol. 17, no. 2 (2025)
Váldodahkki: Yamamoto Shinji
Eará dahkkit: Okada Yukinori
Almmustuhtton:
Springer Nature B.V.
Fáttát:
Liŋkkat:Citation/Abstract
Full Text
Full Text - PDF
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
Govvádus
Abstrákta:18F-fluorodeoxyglucose (18F-FDG) is a radiopharmaceutical that exhibits glucose-like kinetics and is used in positron emission tomography (PET). 18F-FDG is used for cancer diagnosis in clinical practice. However, 18F-FDG uptake is also observed in normal organs, such as the brain, liver, and heart, with high glucose consumption. Moreover, 18F-FDG uptake is also observed in muscles, where its accumulation and radioactivity reflect muscle activity. Dystonia is characterized by excessive muscle movement. Recently, 18F-FDG and technetium-99m-methoxyisobutyl isocyanide ([99mTc]MIBI) have been used for the diagnosis and botulinum toxin therapy evaluation of dystonia.This review aimed to summarize the utility of 18F-FDG-PET for the evaluation of muscle activity and diagnosis of muscle diseases such as dystonia, polymyositis, dermatomyositis, and polymyalgia rheumatica.
ISSN:2168-8184
2154-4786
DOI:10.7759/cureus.79857
Gáldu:Health & Medical Collection